People · Operator

Alexander Farkas

Named in public records as an officer, director or promoter · active 2018–2019 · Other, Other Technology

2
Companies
2
Filings
$75.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Vivvi, Inc.OtherSeries B$48.1M$144.1M2018
Penrose Hill, LtdOther TechnologySeries A$27.6M$291.6M2019
Operator network

Alexander Farkas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian Hirsch · 19 companies · 1 sharedBrian HirschANDREW KAPLAN · 12 companies · 1 sharedANDREW KAPLANRick Segal · 5 companies · 1 sharedRick SegalAmy Nelson · 2 companies · 1 sharedAmy NelsonCharles Bonello · 2 companies · 1 sharedCharles BonelloStefan Szanto · 2 companies · 1 sharedStefan SzantoBenjamin Newton · 1 companies · 1 sharedBenjamin NewtonCharles Bonillo · 1 companies · 1 sharedCharles BonilloChip Meakem · 9 companies · 1 sharedChip MeakemMICHAEL LOEB · 8 companies · 1 sharedMICHAEL LOEBPhilip James · 4 companies · 1 sharedPhilip JamesCharles Meakem · 3 companies · 1 sharedCharles MeakemMark Pinney · 3 companies · 1 sharedMark PinneyOLIVER GARLAND · 1 companies · 1 sharedOLIVER GARLANDZander Farkas · 1 companies · 1 sharedZander FarkasVivvi, Inc. · $48.1M raisedVivvi, Inc.Penrose Hill, Ltd · $27.6M raisedPenrose Hill, LtdAlexander FarkasAF
Alexander Farkas Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Alexander Farkas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian Hirsch119
ANDREW KAPLAN112
Chip Meakem19
MICHAEL LOEB18
Rick Segal15
Philip James14
Charles Meakem13
Mark Pinney13
Stefan Szanto12
Amy Nelson12
Charles Bonello12
Benjamin Newton11
Charles Bonillo11
Zander Farkas11
OLIVER GARLAND11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.